• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Urgent Global Need of Blood Products

October 29, 2019

The current World Health Organization (WHO) guidelines recommend 10-20 blood donations per 1000 individuals, but these guidelines do not take into account demographics, economics, and local epidemiology of specific diseases. In order to gain a better understanding of the global supply of blood products, researchers used data from the WHO Global Status Report on Blood Safety and Availability to estimate blood supply for 195 countries from 2011-2013. To estimate the global need, inpatient databases from the US were used to calculate the units of RBCs, platelets and plasma typically needed for 20 different transfusion scenarios. Based on a mixed-effects spatiotemporal Gaussian-process regression model, the global need for blood products was greater than the supply (304,711,244 units needed and 272,270,243 units supplied), with a need-to-supply ratio of 1.12 (95% uncertainty interval [UI] 1.07-1.16). The majority of countries (119/195; 61%) needed more blood products; those with the greatest unmet need were in sub-Saharan African, south and southeast Asia, and Oceania. Significant variation of need and supply was observed based on regional epidemiology and income, but the blood needs for many countries exceeded donations.

Reference:

Roberts N, James S, Delaney M, Fitzmaurice C. The global need and availability of blood products: a modelling study. The Lancet Haematology 2019

 

Filed Under

  • Blood Donation
  • News
  • RBC Transfusion

Recommended

  • Eculizumab for Treating Cold Agglutinin Disease

  • AABB Clinical Practice Guidelines for RBC Transfusions

  • Fresh Red Blood Cell Transfusions Do Not Improve Outcomes in Critically Ill Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley